Thermo Fisher Scientific upgrades Quick to Clinic

By The Science Advisory Board staff writers

June 15, 2021 -- Thermo Fisher Scientific is showcasing a new version of its Quick to Clinic service for biologic drug developers at the BIO Digital 2021 conference, which is being held June 14-18.

The new version of Quick to Clinic utilizes Thermo Fisher's Gibco Freedom ExpiCHO royalty-free, high-yield expression system that can scale from a research and development environment, according to the firm. It is designed to enable biopharma companies to reach phase I trials and file for investigational new drug (IND) reviews with the U.S. Food and Drug Administration (FDA) in as little as 13 months from transfection.

Quick to Clinic also supports activities such as cell line development, process fit, analytical development, and qualification, Thermo Fisher said.

As a result, companies developing mammalian recombinant proteins can utilize the platform to ramp up quickly from the discovery phase, leveraging toxicology and good manufacturing practices material and documentation provided by Quick to Clinic to file for an IND in a more expedited manner, according to Thermo Fisher.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.